Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Holding(s) in Company

7th Apr 2009 14:38

RNS Number : 2868Q
Allergy Therapeutics PLC
07 April 2009
 



For filings with the FSA include the annex

For filings with issuer exclude the annex 

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Allergy Therapeutics Plc

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 

An event changing the breakdown of voting rights

Other (please specify):______________

3. Full name of person(s) subject to notification obligation:

FIL Limited (FIL)

4. Full name of shareholder(s) (if different from 3):

See attached schedule

5. Date of transaction (and date on which the threshold is crossed or reached if different):

06 April 2009

6. Date on which issuer notified:

07 April 2009

7. Threshold(s) that is/are crossed or reached:

11%

8: Notified Details

A: Voting rights attached to shares

Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights

Direct

Indirect

Direct

Indirect

ISIN

GB00B02LCQ05

9,033,043

9,033,043

8,854,410

8,854,410

10.80

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

Total (A+B)

Number of voting rights

Percentage of voting rights

8,854,410

10.80

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

See attached schedule

Proxy Voting:

10. Name of proxy holder:

FIL Limited (FIL)

11. Number of voting rights proxy holder will cease to hold:

178,633

12. Date on which proxy holder will cease to hold voting rights:

06 April 2009

13. Additional information:

None

14 Contact name:

Amanda Chana

15. Contact :

[email protected]

 

 

 

 

FIL
 
Issuer Name: ALLERGY THERAPEUTICS LTD
 
Current ownership percentage: 10.80%
Total Shares Held: 8,854,410
Issued Share Capital: 81,950,632
 
 

SHARES HELD
NOMINEE
MANAGEMENT COMPANY
105,467
JPMORGAN, BOURNEMOUTH
FIL
8,748,943
JPMORGAN, BOURNEMOUTH
FISL
 
 
 
 
FIL Limited (FIL) is the parent holding company for various direct and indirect subsidiaries, including FIL Fund Management Limited (FFML), FIL Investment Services Ltd (FISL), FIL Gestion (FIGEST), FIL Asset Management (Korea) Limited (FIAKL), FIL Investments Management (Hong Kong) Limited (FIMHK), FIL Pension Management (FPM), Fidelity Investments Japan (FIJ) and FIL Investments International (FII), Investment managers for various non-US investment companies and institutional clients.

 

 

 

For notes on how to complete form TR-1 please see the FSA website. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUBRORKRRSRAR

Related Shares:

Allergy Thera.
FTSE 100 Latest
Value8,601.48
Change58.92